H

HLB Inc
KOSDAQ:028300

Watchlist Manager
HLB Inc
KOSDAQ:028300
Watchlist
Price: 78 800 KRW -0.13%
Market Cap: 10.3T KRW
Have any thoughts about
HLB Inc?
Write Note

Net Margin
HLB Inc

-357.8%
Current
-193%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-357.8%
=
Net Income
-185.8B
/
Revenue
51.9B

Net Margin Across Competitors

Country KR
Market Cap 10.3T KRW
Net Margin
-358%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 38.2B CHF
Net Margin
12%
Country DK
Market Cap 177.1B DKK
Net Margin
19%
Country US
Market Cap 16.3B USD
Net Margin
11%
Country CN
Market Cap 51B CNY
Net Margin
42%
Country US
Market Cap 6.7B USD
Net Margin
29%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country UK
Market Cap 4.6B GBP
Net Margin
7%
Country US
Market Cap 5.6B USD
Net Margin
9%
Country CH
Market Cap 4.7B CHF
Net Margin
12%
No Stocks Found

HLB Inc
Glance View

Market Cap
10.3T KRW
Industry
Health Care

Nestled in the bustling corridors of international commerce, HLB Inc. stands as a dynamic player in the healthcare logistics and biomedical sector. Over the years, it has carved a pivotal niche through its adept coordination of high-stakes operations that drive the backbone of medical supply chains. At the heart of its operations are innovative solutions that ensure medical products — ranging from essential pharmaceuticals to state-of-the-art medical devices — navigate smoothly from manufacturers to healthcare providers. This meticulous orchestration not only bolsters the efficiency of healthcare delivery but also makes HLB Inc. an indispensable ally in the realm of modern medicine. The company’s revenue model thrives on the intricate balance of logistical prowess and cutting-edge biomedical services. By leveraging strategic partnerships and technology-driven process improvement, HLB Inc. delivers unparalleled value in both time efficiency and cost-effectiveness. Service contracts with healthcare institutions and governmental bodies serve as significant revenue channels, as the company deftly integrates its logistics network with client demand. Simultaneously, its investments in research and development keep HLB Inc. at the forefront of healthcare innovation, providing an array of bespoke solutions that cater to the evolving landscape of healthcare needs. This dual approach not only solidifies its financial performance but also reflects a commitment to advancing the frontiers of healthcare accessibility and reliability.

Intrinsic Value
855.5 KRW
Overvaluation 99%
Intrinsic Value
Price
H
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-357.8%
=
Net Income
-185.8B
/
Revenue
51.9B
What is the Net Margin of HLB Inc?

Based on HLB Inc's most recent financial statements, the company has Net Margin of -357.8%.